378 related articles for article (PubMed ID: 31221971)
1. IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection.
Frisbee AL; Saleh MM; Young MK; Leslie JL; Simpson ME; Abhyankar MM; Cowardin CA; Ma JZ; Pramoonjago P; Turner SD; Liou AP; Buonomo EL; Petri WA
Nat Commun; 2019 Jun; 10(1):2712. PubMed ID: 31221971
[TBL] [Abstract][Full Text] [Related]
2. Investigating the impact of antibiotic-induced dysbiosis on protection from
Uddin MJ; Thompson B; Leslie JL; Fishman C; Sol-Church K; Kumar P; Petri WA
mBio; 2024 Mar; 15(3):e0333823. PubMed ID: 38376154
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to Clostridium difficile infection.
Madan R; Petri WA
Trends Mol Med; 2012 Nov; 18(11):658-66. PubMed ID: 23084763
[TBL] [Abstract][Full Text] [Related]
4. The microbiota and immune response during Clostridium difficile infection.
Buonomo EL; Petri WA
Anaerobe; 2016 Oct; 41():79-84. PubMed ID: 27212111
[TBL] [Abstract][Full Text] [Related]
5. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice.
McDermott AJ; Falkowski NR; McDonald RA; Pandit CR; Young VB; Huffnagle GB
Immunology; 2016 Jan; 147(1):114-24. PubMed ID: 26455347
[TBL] [Abstract][Full Text] [Related]
8. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis.
Jarchum I; Liu M; Shi C; Equinda M; Pamer EG
Infect Immun; 2012 Sep; 80(9):2989-96. PubMed ID: 22689818
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis.
Jarchum I; Liu M; Lipuma L; Pamer EG
Infect Immun; 2011 Apr; 79(4):1498-503. PubMed ID: 21245274
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile colitis: pathogenesis and host defence.
Abt MC; McKenney PT; Pamer EG
Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
[TBL] [Abstract][Full Text] [Related]
11. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.
Chen X; Yang X; de Anda J; Huang J; Li D; Xu H; Shields KS; Džunková M; Hansen J; Patel IJ; Yee EU; Golenbock DT; Grant MA; Wong GCL; Kelly CP
Gastroenterology; 2020 Dec; 159(6):2181-2192.e1. PubMed ID: 32841647
[TBL] [Abstract][Full Text] [Related]
12. Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile.
Viladomiu M; Hontecillas R; Pedragosa M; Carbo A; Hoops S; Michalak P; Michalak K; Guerrant RL; Roche JK; Warren CA; Bassaganya-Riera J
PLoS One; 2012; 7(10):e47525. PubMed ID: 23071818
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice.
Sadighi Akha AA; McDermott AJ; Theriot CM; Carlson PE; Frank CR; McDonald RA; Falkowski NR; Bergin IL; Young VB; Huffnagle GB
Immunology; 2015 Apr; 144(4):587-97. PubMed ID: 25327211
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota.
Nagao-Kitamoto H; Leslie JL; Kitamoto S; Jin C; Thomsson KA; Gillilland MG; Kuffa P; Goto Y; Jenq RR; Ishii C; Hirayama A; Seekatz AM; Martens EC; Eaton KA; Kao JY; Fukuda S; Higgins PDR; Karlsson NG; Young VB; Kamada N
Nat Med; 2020 Apr; 26(4):608-617. PubMed ID: 32066975
[TBL] [Abstract][Full Text] [Related]
15. Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.
Buonomo EL; Cowardin CA; Wilson MG; Saleh MM; Pramoonjago P; Petri WA
Cell Rep; 2016 Jul; 16(2):432-443. PubMed ID: 27346351
[TBL] [Abstract][Full Text] [Related]
16. Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop.
Hasegawa M; Kamada N; Jiao Y; Liu MZ; Núñez G; Inohara N
J Immunol; 2012 Sep; 189(6):3085-91. PubMed ID: 22888139
[TBL] [Abstract][Full Text] [Related]
17. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B.
Cook L; Rees WD; Wong MQ; Peters H; Levings MK; Steiner TS
Gastroenterology; 2021 May; 160(6):2155-2158.e4. PubMed ID: 33444574
[No Abstract] [Full Text] [Related]
19. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
